141 related articles for article (PubMed ID: 6117124)
21. Nutrient control of brain neurotransmitter synthesis and function.
Anderson GH; Johnston JL
Can J Physiol Pharmacol; 1983 Mar; 61(3):271-81. PubMed ID: 6132676
[TBL] [Abstract][Full Text] [Related]
22. The importance of synapsin I and II for neurotransmitter levels and vesicular storage in cholinergic, glutamatergic and GABAergic nerve terminals.
Bogen IL; Haug KH; Roberg B; Fonnum F; Walaas SI
Neurochem Int; 2009; 55(1-3):13-21. PubMed ID: 19428802
[TBL] [Abstract][Full Text] [Related]
23. Nutrients that modify brain function.
Wurtman RJ
Sci Am; 1982 Apr; 246(4):50-9. PubMed ID: 6123150
[No Abstract] [Full Text] [Related]
24. Comparative effects of single dose and repeated oral tryptophan administration on indoleamine synthesis and memory functions in rats.
Khaliq S; Haider S; Haleem DJ
Pak J Pharm Sci; 2007 Jan; 20(1):71-6. PubMed ID: 17337433
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
Bird TD; Stranahan S; Sumi SM; Raskind M
Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
[TBL] [Abstract][Full Text] [Related]
26. Amino acid precursors of monoamine neurotransmitters and some factors influencing their supply to the brain.
Daniel PM; Moorhouse SR; Pratt OE
Psychol Med; 1976 May; 6(2):277-86. PubMed ID: 12522
[TBL] [Abstract][Full Text] [Related]
27. Influences of nutrition on brain differentiation mediated by systemic hormones and neurotransmitters.
Dörner G
Bibl Nutr Dieta; 1986; (38):27-38. PubMed ID: 2870710
[No Abstract] [Full Text] [Related]
28. Alzheimer's disease and the new neuroscience.
Wortis J
Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248
[No Abstract] [Full Text] [Related]
29. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase.
Fu AL; Li Q; Dong ZH; Huang SJ; Wang YX; Sun MJ
Neurosci Lett; 2004 Sep; 368(3):258-62. PubMed ID: 15364407
[TBL] [Abstract][Full Text] [Related]
30. Amino acid control of neurotransmitter synthesis and release: physiological and clinical implications.
Lehnert H; Wurtman RJ
Psychother Psychosom; 1993; 60(1):18-32. PubMed ID: 7901866
[TBL] [Abstract][Full Text] [Related]
31. Serotonin and amino acids: partners in delirium pathophysiology?
van der Mast RC; Fekkes D
Semin Clin Neuropsychiatry; 2000 Apr; 5(2):125-31. PubMed ID: 10837101
[TBL] [Abstract][Full Text] [Related]
32. The metabolism of some neurotransmitters in ageing and dementia disorders.
Gottfries CG
Gerontology; 1982; 28 Suppl 2():11-9. PubMed ID: 6131853
[No Abstract] [Full Text] [Related]
33. Neurotransmitter synthesis in the tectum of the tiger salamander Ambystoma tigrinum.
Gruberg ER; Greenhouse GA
Brain Res; 1973 Oct; 61():435-7. PubMed ID: 4149307
[No Abstract] [Full Text] [Related]
34. Distribution of neurotransmitters and their effects on glucagon secretion from the in vitro normal and diabetic pancreatic tissues.
Adeghate E; Ponery AS; Pallot DJ; Singh J
Tissue Cell; 2000 Jun; 32(3):266-74. PubMed ID: 11037798
[TBL] [Abstract][Full Text] [Related]
35. Neurotransmitters, precursors and metabolites in spinal cord and brain of Lewis rats with EAE.
Honegger CG; Isler H
Prog Clin Biol Res; 1984; 146():131-8. PubMed ID: 6201886
[No Abstract] [Full Text] [Related]
36. Inhibition of acetylcholine synthesis and tyrosine nitration induced by peroxynitrite are differentially prevented by antioxidants.
Guermonprez L; Ducrocq C; Gaudry-Talarmain YM
Mol Pharmacol; 2001 Oct; 60(4):838-46. PubMed ID: 11562447
[TBL] [Abstract][Full Text] [Related]
37. [Neurotransmitter anomalies in Alzheimer's disease].
Berger B
Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
[TBL] [Abstract][Full Text] [Related]
38. Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats.
Takeo S; Hayashi H; Miyake K; Takagi K; Tadokoro M; Takagi N; Oshikawa S
Br J Pharmacol; 1997 Jun; 121(3):477-84. PubMed ID: 9179389
[TBL] [Abstract][Full Text] [Related]
39. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
[TBL] [Abstract][Full Text] [Related]
40. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
